ThermoGenesis (THMO) - גידול ברווח למניה בשנה הנוכחית

ThermoGenesis is developing a global network of biobanks, creating automated cell processing systems to mitigate regulatory threats. The implementation of robots for stem material separation minimizes manual labor. Measurable YoY EPS growth illustrates the dynamics of these processes, where 0.00 forms the current metric value. However, a working capital deficit and slow technology adoption by centers could hinder further progress.

This indicator captures the annual percentage change in net income per share, reflecting the efficiency of capital generation for shareholders. The calculation is based on comparing the current EPS with the same period last year to assess business resilience amid market contraction. An analysis of the YoY earnings per share dynamics for ThermoGenesis reveals that profitability depends on the pace of laboratory digitalization and liquidity risks resulting from limited sales volumes.